Literature DB >> 23289600

Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease.

A N Ananthakrishnan1, V S Gainer, R G Perez, T Cai, S-C Cheng, G Savova, P Chen, P Szolovits, Z Xia, P L De Jager, S Y Shaw, S Churchill, E W Karlson, I Kohane, R H Perlis, R M Plenge, S N Murphy, K P Liao.   

Abstract

BACKGROUND: Psychiatric co-morbidity, in particular major depression and anxiety, is common in patients with Crohn's disease (CD) and ulcerative colitis (UC). Prior studies examining this may be confounded by the co-existence of functional bowel symptoms. Limited data exist examining an association between depression or anxiety and disease-specific endpoints such as bowel surgery. AIMS: To examine the frequency of depression and anxiety (prior to surgery or hospitalisation) in a large multi-institution electronic medical record (EMR)-based cohort of CD and UC patients; to define the independent effect of psychiatric co-morbidity on risk of subsequent surgery or hospitalisation in CD and UC, and to identify the effects of depression and anxiety on healthcare utilisation in our cohort.
METHODS: Using a multi-institution cohort of patients with CD and UC, we identified those who also had co-existing psychiatric co-morbidity (major depressive disorder or generalised anxiety). After excluding those diagnosed with such co-morbidity for the first time following surgery, we used multivariate logistic regression to examine the independent effect of psychiatric co-morbidity on IBD-related surgery and hospitalisation. To account for confounding by disease severity, we adjusted for a propensity score estimating likelihood of psychiatric co-morbidity influenced by severity of disease in our models.
RESULTS: A total of 5405 CD and 5429 UC patients were included in this study; one-fifth had either major depressive disorder or generalised anxiety. In multivariate analysis, adjusting for potential confounders and the propensity score, presence of mood or anxiety co-morbidity was associated with a 28% increase in risk of surgery in CD (OR: 1.28, 95% CI: 1.03-1.57), but not UC (OR: 1.01, 95% CI: 0.80-1.28). Psychiatric co-morbidity was associated with increased healthcare utilisation.
CONCLUSIONS: Depressive disorder or generalised anxiety is associated with a modestly increased risk of surgery in patients with Crohn's disease. Interventions addressing this may improve patient outcomes.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23289600      PMCID: PMC3552092          DOI: 10.1111/apt.12195

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  49 in total

Review 1.  The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited.

Authors:  Amelia N Dubovsky; Sheila Arvikar; Theodore A Stern; Lloyd Axelrod
Journal:  Psychosomatics       Date:  2012 Mar-Apr       Impact factor: 2.386

2.  Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach.

Authors:  Ashwin N Ananthakrishnan; Tianxi Cai; Guergana Savova; Su-Chun Cheng; Pei Chen; Raul Guzman Perez; Vivian S Gainer; Shawn N Murphy; Peter Szolovits; Zongqi Xia; Stanley Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Robert M Plenge; Katherine P Liao
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

3.  Depression predicts repeated heart failure hospitalizations.

Authors:  Tricia J Johnson; Sanjib Basu; Barbara A Pisani; Elizabeth F Avery; Jose C Mendez; James E Calvin; Lynda H Powell
Journal:  J Card Fail       Date:  2012-01-27       Impact factor: 5.712

4.  The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

Authors:  P Persoons; S Vermeire; K Demyttenaere; B Fischler; J Vandenberghe; L Van Oudenhove; M Pierik; T Hlavaty; G Van Assche; M Noman; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2005-07-15       Impact factor: 8.171

Review 5.  Psychological interventions for treatment of inflammatory bowel disease.

Authors:  Antje Timmer; Jan C Preiss; Edith Motschall; Gerta Rücker; Günther Jantschek; Gabriele Moser
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

6.  Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases.

Authors:  Lena Palmer; Hans Herfarth; Carol Q Porter; Lynn A Fordham; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

7.  Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity.

Authors:  Houssam E Mardini; Kevin E Kip; John W Wilson
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

8.  Factors associated with radiation exposure in patients with inflammatory bowel disease.

Authors:  Z Levi; E Fraser; R Krongrad; R Hazazi; O benjaminov; J meyerovitch; O B Tal; A Choen; Y Niv; G Fraser
Journal:  Aliment Pharmacol Ther       Date:  2009-12-01       Impact factor: 8.171

9.  Predicting relapse in Crohn's disease: a biopsychosocial model.

Authors:  A Bitton; P L Dobkin; M D Edwardes; M J Sewitch; J B Meddings; S Rawal; A Cohen; S Vermeire; L Dufresne; D Franchimont; G E Wild
Journal:  Gut       Date:  2008-04-07       Impact factor: 23.059

10.  Health care costs associated with depressive and anxiety disorders in primary care.

Authors:  G Simon; J Ormel; M VonKorff; W Barlow
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

View more
  44 in total

1.  Depression Predicts Prolonged Length of Hospital Stay in Pediatric Inflammatory Bowel Disease.

Authors:  Perseus V Patel; Matthew S Pantell; Melvin B Heyman; Sofia Verstraete
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-11       Impact factor: 2.839

2.  Predicting Costs of Care for Patients With Inflammatory Bowel Diseases.

Authors:  Benjamin Click; David G Binion; Alyce M Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-03       Impact factor: 11.382

3.  Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.

Authors:  Sumedha V Chablani; Claudia Ramos-Rivers; David G Binion; Eva Szigethy
Journal:  Dig Dis Sci       Date:  2018-07-19       Impact factor: 3.199

4.  Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.

Authors:  Giovanni Maconi; Daniele Gridavilla; Caterina Viganò; Roberta Sciurti; Anil K Asthana; Federica Furfaro; Federica Re; Sandro Ardizzone; Gabriella Ba
Journal:  Int J Colorectal Dis       Date:  2014-07-02       Impact factor: 2.571

5.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Elizabeth Scoville; Gauree G Konijeti; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

6.  Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.

Authors:  Sara Horst; Andrew Chao; Michael Rosen; Anne Nohl; Caroline Duley; Julianne H Wagnon; Dawn B Beaulieu; Warren Taylor; Lawrence Gaines; David A Schwartz
Journal:  Dig Dis Sci       Date:  2014-10-02       Impact factor: 3.199

7.  Semi-supervised Learning for Phenotyping Tasks.

Authors:  Dmitriy Dligach; Timothy Miller; Guergana K Savova
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

8.  Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record.

Authors:  Chen Lin; Elizabeth W Karlson; Dmitriy Dligach; Monica P Ramirez; Timothy A Miller; Huan Mo; Natalie S Braggs; Andrew Cagan; Vivian Gainer; Joshua C Denny; Guergana K Savova
Journal:  J Am Med Inform Assoc       Date:  2014-10-25       Impact factor: 4.497

9.  Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  J Crohns Colitis       Date:  2014-02-19       Impact factor: 9.071

10.  Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Click; Claudia Ramos Rivers; Ioannis E Koutroubakis; Dmitriy Babichenko; Alyce M Anderson; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Miguel Regueiro; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.